Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein

Journal of Medical Virology

Volumn 62, Issue 1, 2000, Pages 60-69

  Yoshikawa, Tetsushi ^a,d   Ihira, Masaru ^a   Suzuki, Kyoko ^a   Suga, Sadao ^a   Iida, Keiji ^b   Saito, Yumiko ^b   Asonuma, Katsuhiro ^c   Tanaka, Koichi ^c   Asano, Yoshizo ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SRL INC   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Distribution; Human parvovirus B19; Subtype

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENETIC POLYMORPHISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARVOVIRUS; POINT MUTATION; SEQUENCE ANALYSIS; VIRUS ISOLATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; GENOTYPE; HUMAN; OPEN READING FRAMES; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; VIRAL NONSTRUCTURAL PROTEINS;

DNA VIRUSES; PARVOVIRUS;

EID: 0033866169     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200009)62:1<60::AID-JMV10>3.0.CO;2-X     Document Type: Article

References (48)

1. Human parvovirus infection in pregnancy and hydrops fetalis
2. Human parvovirus, the cause of erythema infectiosum (fifth disease)?
3. Diagnosis of human parvovirus infection by dot-hybridization using cloned viral DNA
4. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates
5. Human parvovirus B19 infection in hemophiliacs first infused with treated clotting factor concentrates
6. In vitro identification of a B19 parvovirus promoter
7. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural protein
8. Detection of human parvovirus using a molecularly cloned probe
9. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens
10. Diagnostic assays with monoclonal antibodies for serum parvovirus-like virus (SPLV)
11. Parvovirus-like particles in human sera
12. Parvovirus infection, leukemia, and immunodeficiency
13. Cloning of the human parvovirus B19 genome and structure analysis of its palindromic termini
14. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency
15. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus
16. Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing
17. Surveillance for infectious disease Japan: The estimation for infectious disease
18. Serologically proved intra-uterine infection with parvovirus
19. Detection of human parvovirus B19 DNA by using the polymerase chain reaction
20. Persistent B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia
21. Chronic bone marrow failure due to persistent B19 parvovirus infection
22. B19 parvovirus DNA in solvent/detergent-treated anti-hemophilia concentrates
23. Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition
24. Differential transcription, without replication of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization
25. Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its function for viral DNA replication, late promoter trans activation and cytotoxicity
26. Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in in vitro
27. Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction
28. Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection
29. Transmission of serum parvovirus-like virus by clotting-factor concentrates
30. Hypothesis: The aplastic crisis of hereditary spherocytosis is due to a single transmissible agent
31. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells
32. Parvovirus infection and hypoplastic crisis in sickle-cell anemia
33. Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia
34. Human parvovirus-associated arthritis: A clinical and laboratory description
35. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface
36. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies
37. Screening of blood donors for human parvovirus B19
38. Viral arthritis
39. Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus-like agent
40. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
41. Mutational analysis of conserved tyrosines in the NS-1 protein of the parvovirus minute virus of mice
42. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product
43. The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: A correlation between genome type and prevalence
44. Antibodies to parvovirus B19 NS-1 protein in infected individuals
45. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis
46. Human parvovirus arthropathy
47. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade
48. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response